Revolution Medicines, Inc. (RVMD) Misses Q3 EPS by 20c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q3 EPS of ($1.61), $0.20 worse than the analyst estimate of ($1.41). Revenue for the quarter came in at $0 versus the consensus estimate of $1.95 million.

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• Venu Holding (VENU) PT Lowered to $8.70 at Freedom Broker
• S&P affirms Nvidia rating at AA on Ohio campus guarantee
• Klarna shares tumble on weak full-year revenue guidance